Merck's $ 8 cancer coverage is facing the first case of American judges




Jurors will test if Merck blocked side effects reports from drug architects and launched a misleading marketing campaign to turn the drug into a blockbuster product. Read more



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *